HIVANO Intent to Use Trademark Application

The USPTO has received an intent-to-use trademark application (TM99722503) for the mark 'HIVANO'. The application covers a wide range of goods including athletic apparel, footwear, and various supplements (probiotic, homeopathic, mineral, herbal, vitamin, calcium, food, dietary, nutritional, and natural herbal). It also includes services related to nutrition counseling and information provision.

POWERSTOVE Trademark Application Published for Opposition

The USPTO has published the trademark application for 'POWERSTOVE' for opposition. The application covers a range of products including personal sexual lubricants, dietary supplements, pet supplements, vitamins, and other health-related items. The publication date for opposition is March 25, 2026.

TEMIMAR trademark application published for opposition

The USPTO has published the trademark application for 'TEMIMAR' for opposition. The application covers natural herbal supplements, vitamin supplements, and other health-related food products. The publication date is March 25, 2026.

7 LIFE Trademark Application Published for Opposition

The USPTO has published the trademark application for '7 LIFE' for opposition. The application, filed on March 24, 2026, is for dietary supplements. The publication date is March 25, 2026, initiating a period for potential opposition.

CHIGGER OFF Intent to Use Trademark Application

The USPTO has received an Intent to Use trademark application for 'CHIGGER OFF' for topical dermatological preparations. The application was filed on March 24, 2026, with an effective date of March 25, 2026. This filing pertains to a new product intended to treat insect bites and stings.

FIBRIBION Trademark Publication

The USPTO has published the FIBRIBION trademark application for opposition. The application covers nutritional supplements, probiotic compositions, and dietary supplements. The publication date is March 25, 2026.

JUVONA intent to use trademark application filed

The USPTO has received an intent-to-use trademark application for the mark 'JUVONA' filed on March 25, 2026. The application covers goods including dietary supplements, nutritional supplements, and nutraceuticals for human consumption.

HEALTHYBLOOD Trademark Published for Opposition

The USPTO has published the HEALTHYBLOOD trademark application for opposition. The application covers various types of nutritional and dietary supplements. The publication date was March 25, 2026, with a filing date of March 24, 2026.

VERIXA trademark application published for opposition

The USPTO has published the trademark application for 'VERIXA' for opposition. The application covers insect repellents, insecticides, and rodenticides. The filing date was March 24, 2026, and the publication date is March 25, 2026.

BIOTHRIVE Trademark Application - Intent to Use

The USPTO has received an intent-to-use trademark application for the mark 'BIOTHRIVE' filed on March 24, 2026. The application covers health food supplements, dietary supplements, herbal supplements, and vitamin and mineral supplements.

ELTHYSIA Trademark Application - Intent to Use

The USPTO has recorded an intent-to-use trademark application for the mark 'ELTHYSIA'. The application covers a wide range of products including vitamins, dietary supplements, and pet supplements. The filing date for this application was March 24, 2026.

ASTANEURO Trademark Application Published for Opposition

The USPTO has published the trademark application for ASTANEURO, filed on March 24, 2026, for opposition. This notice indicates the application is now open for challenges from other parties before it can be registered.

NALIRFAL Trademark Application Published for Opposition

The USPTO has published the trademark application for NALIRFAL, which includes a variety of dietary and nutritional supplements. The application was published for opposition on March 25, 2026, with a filing date of March 24, 2026. This publication initiates a period during which other parties may oppose the trademark registration.

NOURISHA intent to use trademark application details

The USPTO has recorded an intent-to-use trademark application (TM99692572) for the mark 'NOURISHA'. The application covers a range of pharmaceutical and food-related products, including milk-based nutritional supplements and dietetic preparations. The filing date for this application was March 10, 2026.

KYNTO Trademark Published for Opposition

The USPTO has published the KYNTO trademark application for opposition, related to dietary supplements. The application was filed on March 24, 2026, and the publication date for opposition is March 25, 2026. This marks a step in the trademark registration process.

JOINT AND JOINT Trademark Published for Opposition

The USPTO has published the trademark application for 'JOINT AND JOINT' for health food supplements, initiating a 30-day opposition period. The application was filed on March 24, 2026, and published for opposition on March 25, 2026.

Vitaminloft Intent to Use Trademark Application

The USPTO has published details for an intent-to-use trademark application for the mark 'VITAMINLOFT'. The application covers a wide range of pharmaceutical and health-related products, including supplements, vitamins, topical preparations, and disinfectants.

VALISSE intent to use trademark application filed

The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application for the mark 'VALISSE'. The application, filed on March 24, 2026, covers health food supplements, dietary supplements, herbal supplements, and vitamin and mineral supplements.

KARENZA Trademark Intent to Use Application

The USPTO has received an intent-to-use trademark application for the mark 'KARENZA' for use with dietary supplements. The application was filed on March 24, 2026, and is designated for Class 005.

Pumping Device Patent Application Published

The USPTO published a patent application for a new pumping device designed for feeding liquid to patients. The application, filed on September 25, 2024, describes a disposable pumping cartridge and a reusable drive unit, aiming for economical assembly and use.

Implantable Reservoir for Iontophoresis Drug Delivery System

The USPTO has published a new patent application (US20260083966A1) for an implantable reservoir designed for iontophoresis drug delivery systems. The application details a reservoir for local drug delivery through internal or external body tissue, potentially including chemotherapeutic agents or ribonucleic acid molecules.

Patent Application for Patient Health Monitoring Device

The USPTO has published a new patent application (US20260083959A1) for a patient health monitoring device and method. The application details a device that processes pressure signals to monitor a patient's health state. This is a routine publication of a new patent application.

Medical Fluid Pump Patent Application

The USPTO has published a new patent application (US20260083958A1) for a fluid pump device, particularly for medical applications. The application was filed on December 2, 2025, and published on March 26, 2026.

Medical Device Patent: Circulatory Support System with Diaphragm Pump

The USPTO has published a new patent application (US20260083957A1) for a circulatory support system with a diaphragm pump, assigned to Boston Scientific Scimed, Inc. The application details a percutaneous circulatory support device system designed to pump blood.

Mechanical Circulatory Support System Patent Application

The USPTO has published a new patent application (US20260083956A1) for a mechanical circulatory support system with a repositioning sheath, assigned to Boston Scientific Scimed, Inc. The application details a medical device system designed to pump blood from a patient's heart ventricle to the vasculature.

USPTO Patent Application for Blood Pump Outflow Window Markings

The USPTO has published a new patent application (US20260083955A1) filed by Boston Scientific Scimed, Inc. The application describes percutaneous blood pump outflow window markings for a circulatory support device. This is a routine publication of a patent application.

Shielded Bag for Radioactive Medicaments Delivery System

The USPTO has published a new patent application (US20260083981A1) for a shielded bag designed for delivering radioactive medicaments. The application, filed by Christopher James Franzese and Martin Michael Coyne, III, details a multi-layered container for storing and transporting radiopharmaceuticals.

Method for preparing biologically active complexes using polypeptides and oleic acid

Method for preparing biologically active complexes using polypeptides and oleic acid

Patent Application for Chromatographic Fractionation Method

The USPTO has published a new patent application (US20260085089A1) detailing a method and apparatus for continuous gradient elution chromatographic fractionation. The application, filed on September 12, 2023, describes a process for separating products of interest from impurities using chromatography matrices and elution solutions.

Method for Reducing Host Cell Proteins in Affinity Chromatography

The USPTO has published a patent application from Genentech, Inc. detailing a method for purifying antibodies by reducing host cell proteins using a low conductivity aqueous solution in affinity chromatography. This application, filed on December 2, 2025, describes a specific purification technique for biopharmaceutical products.

Patent Application: Peptide Binds Trop2 for Cancer Treatment

The USPTO has published a patent application (US20260085091A1) from Kyungpook National University Industry-Academic Cooperation Foundation for a peptide that selectively binds to Trop 2. The peptide is intended for targeted therapeutic agents and anticancer drugs for resistant cancers such as breast, pancreatic, and cholangiocarcinoma.

Melanocortin Receptor Ligands Patent Application

The USPTO has published a new patent application (US20260085092A1) for compounds acting as ligands for melanocortin receptors. The application details specific compounds and their potential use in treating mammals, filed by inventors Zeng Xin Dong and Jacques-Pierre Moreau.

Stapled Peptide and Use Thereof Patent Application

The USPTO has published a patent application (US20260085094A1) for a stapled peptide and its use, filed by inventors Zhixiang PAN, Haiying HE, Zhigan JIANG, and Shuhui CHEN. The application details a series of stapled peptides, specifically relating to polypeptides with sequences shown in formulas (I-1)-(I-5) and (II-6), and their pharmaceutically acceptable salts.

Patent Application for AAV Capsid Variants and Uses

The USPTO has published a new patent application (US20260085095A1) detailing adeno-associated virus (AAV) capsid variants and their uses. The application was filed on June 1, 2023, and is scheduled for publication on March 26, 2026. This represents a new disclosure in the field of gene therapy vectors.

Stabilized trimeric class I fusion proteins patent application

The USPTO has published a patent application (US20260085096A1) for stabilized trimeric class I fusion proteins. The application details specific mutations in the HR2 domain to enhance protein stability. This is a routine publication of a new patent application.

US Patent Application for Antigen Production Methods

The USPTO has published a new patent application (US20260085100A1) from The Wistar Institute of Anatomy and Biology detailing methods for manufacturing individualized vaccines. The application focuses on nucleic acid molecules encoding neoantigens specific to tumor antigens for use in subject immunization.

Novel Platelet Derived Growth Factor Peptide Mimetic for Cardiac Repair

The USPTO has published a patent application (US20260085101A1) for a novel platelet-derived growth factor peptide mimetic designed for cardiac repair, particularly post-infarction. The application details specific compounds, their preparation, and methods of use.

Patent Application for Synthetic Promoters and Circuits in Cancer Cells

The USPTO has published a patent application (US20260085102A1) for nucleic acid molecules designed to specifically express sequences of interest in cancer cells. The application details synthetic promoters and circuits for use in cancer treatment.

Long-acting insulin compound for treating diabetes

The USPTO has published a patent application (US20260085103A1) for a long-acting insulin compound designed for treating diabetes. The application details the compound's use in pharmaceutical compositions for conditions including type-I, type-II, and gestational diabetes.

Patent Application for Detecting Immune Cells Using Fusion Proteins

The USPTO has published a new patent application (US20260085104A1) detailing fusion proteins for detecting and isolating immune cells. The application, filed by Patrick Schlegel, describes specific fusion proteins involving a dysfunctional purinergic P2X7 receptor epitope and an antibody Fc region.

MAGEA4 Specific T Cell Receptors Patent Application

The USPTO has published a patent application (US20260085105A1) filed by Amgen Inc. for recombinant T-cell receptors designed to selectively recognize MAGE-A4-derived peptides. The application details screening for cross-reactivity and alloreactivity.

Chimeric Antigen Receptor System for Signalling

The USPTO has published a new patent application, US20260085106A1, detailing a chimeric antigen receptor (CAR) system. This system is designed to control signalling based on the presence or absence of a specific agent, potentially impacting the development of targeted therapies.

Ginkgo Bioworks Patent for Protein Production and Secretion Systems

The USPTO has published a new patent application (US20260085107A1) filed by Ginkgo Bioworks, Inc. The patent describes expression systems for enhanced production and secretion of proteins, including specific examples like bovine lactoferrin. This application is part of the ongoing patent process for novel biotechnological methods.

Methods for Separating Chelator from Mixture Using Chromatography

The USPTO has published a new patent application, US20260085108A1, detailing methods for separating a chelator from a mixture using chromatography. This application, filed on September 8, 2023, by inventors Jason Huang and Qiang Li, describes techniques useful in adjusting the concentration of chelators in protein compositions.

Patent Application: Filtration Condition Evaluation and Cell Product Production

The USPTO has published a new patent application (US20260085109A1) from Asahi Kasei Life Science Corporation detailing a method for evaluating filtration conditions and producing cell products. The application was filed on November 14, 2023, and published with a projected application date of March 26, 2026.

Patent Application: Production Method for Product to Prevent Membrane Clogging

The USPTO has published a patent application from FUJIFILM Corporation detailing a production method for a product that aims to prevent membrane clogging during cell culture. The method involves specific mathematical expressions related to poloxamer concentration, product concentration, and hydrophobicity index to optimize the cell culture process.

Patent Application for SLIT2 Related Compositions and Methods

The USPTO has published a new patent application (US20260085111A1) filed by EVEREST MEDICINES (SINGAPORE) PTE. LTD. The application relates to antibodies that bind to SLIT2 and related substitution mutants, including their manufacture and use.

Patent Application for Free LIGHT Detection and Treatment

The USPTO has published a patent application (US20260085112A1) from Avalo Therapeutics, Inc. for methods of detecting and treating conditions associated with elevated free LIGHT using anti-LIGHT antibodies. The application covers methods for diagnosing conditions like acute lung injury, ARDS, and Crohn's Disease.

All-in-one Agonistic Antibodies Patent Application

The USPTO has published a patent application (US20260085113A1) filed by Hoffmann-La Roche Inc. on October 2, 2025. The application describes antigen binding molecules comprising biparatopic target-binding domains and cytokine receptor-binding domains designed to selectively activate cytokine receptors.

Patent Application: Multispecific Binding Constructs Against Checkpoint Molecules

The USPTO has published a new patent application (US20260085121A1) from Compass Therapeutics, LLC, detailing multispecific binding constructs against checkpoint molecules. The application focuses on compositions and methods for inhibiting tumor evasion by reducing immune checkpoint suppression, specifically blocking interactions between PD-1 and its ligand.